Corrigendum: Transarterial chemoembolization combined with lenvatinib versus transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis

Detalles Bibliográficos
Autores principales: Liu, Jun-Ning, Li, Ji-Jiang, Yan, Shu, Zhang, Guang-Nian, Yi, Peng-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325674/
https://www.ncbi.nlm.nih.gov/pubmed/37427117
http://dx.doi.org/10.3389/fonc.2023.1233247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325674/
https://www.ncbi.nlm.nih.gov/pubmed/37427117
http://dx.doi.org/10.3389/fonc.2023.1233247

Ejemplares similares